RX Lite 21013 Pill Bottle: Toddler Gains Access to Medication Despite Proper Closure

July 9, 2026 — An incident report details a 22-month-old toddler accessing medication from a “properly closed” RX Lite 21013 pill bottle, manufactured by Pacific Management Holdings, LLC dba Pharmacy-Lite Packaging, raising concerns about its child-resistant features. The parent thankfully intervened before ingestion, preventing a potential tragedy.

Product Details

Brand Name: RX Lite
Manufacturer: Pacific Management Holdings, LLC dba Pharmacy-Lite Packaging
Model: 21013
Retailer: Dans Pharmacy
Incident Report Number: 20260617-C8A28-2147316419
Farzan Law Serving Clients Across California

Incident Overview

On June 17, 2026, a consumer reported that their 22-month-old daughter gained access to medication stored in an RX Lite 21013 pill bottle. According to the report, the bottle was “properly closed,” indicating that the child-resistant mechanism was engaged as intended. Despite this, the toddler was able to open the container and retrieve the medication. The incident occurred when the child managed to get ahold of the bottle. Fortunately, the parent noticed the child with the bottle and intervened just moments before she could ingest any of the pills, preventing a potentially fatal outcome.

Safety Concerns

This incident points to a critical failure in the child-resistant design of the RX Lite 21013 pill bottle, posing severe safety risks, particularly for young children.

  • Immediate Dangers: The primary and most urgent danger is accidental poisoning or overdose. If a child ingests medication, even a small amount, it can lead to severe health complications, organ damage, or even death, depending on the type and dosage of the medication. Immediate medical intervention, often involving emergency room visits or hospitalization, would be required.
  • Long-Term Risks: While this incident was fortunately caught before ingestion, repeated failures of child-resistant packaging could lead to chronic exposure to medication in children, or severe long-term health consequences from a single, larger ingestion event.
  • Who Might Be Affected: Young children, especially toddlers (like the 22-month-old in this report) and infants, are most at risk. Their natural curiosity, developing motor skills, and tendency to explore objects by putting them in their mouths make them highly vulnerable to medication access. Parents, guardians, and caregivers who rely on child-resistant packaging for safety are also indirectly affected by this potential product defect.
  • Property Damage Potential: There is no direct property damage potential associated with this type of incident; the primary concern is severe personal injury or death.

What Consumers Should Do

Given the reported failure of the RX Lite 21013 pill bottle’s child-resistant features, consumers who use this product should take immediate action to ensure the safety of their households.

  • Immediate Steps to Take:
  • Immediately secure all medications, regardless of their packaging, in locations completely out of reach and sight of children. This includes high shelves or locked cabinets.
  • If you suspect a child has ingested any medication, call Poison Control immediately at 1-800-222-1222 and seek emergency medical attention.
  • How to Check if You Own the Affected Product:
  • Inspect your pill bottles for the brand “RX Lite” and look for the model number “21013.” This information may be molded into the plastic or printed on the bottom or side of the bottle.
  • Even if the child-resistant cap seems to function, do not rely solely on it if you have young children in the home.
  • Prevention Measures:
  • Always store medications in their original containers to keep dosage information and instructions readily available.
  • Never leave medications unattended, even for a moment, when children are present.
  • Educate older children and teenagers about the dangers of medications and the importance of keeping them secure.
  • Dispose of expired or unused medications safely through community take-back programs or by following FDA guidelines.
  • Reporting Procedures:
  • If you have experienced a similar incident or believe your RX Lite 21013 pill bottle is defective, report it immediately to the U.S. Consumer Product Safety Commission (CPSC) at www.SaferProducts.gov. Your report helps identify dangerous products and prevent future injuries.

Manufacturer’s Response

No manufacturer response has been provided in the incident report.

Legal Help Available

If you or a loved one has been injured by a defective product or suffered property damage due to a product malfunction, you may be entitled to compensation. The experienced product liability attorneys at Farzan Law understand the complexities of defective product cases and can help you navigate the legal process. Farzan Law is a California based Personal Injury law firm focusing on protecting the rights of those wrongfully injured.

Licensed to practice law ONLY in California.

Contact us today for a free consultation: 424-325-3112

Our legal team has successfully represented clients in product liability cases involving defective appliances, automotive defects, medical devices, and consumer products. We work on a contingency fee basis, which means you don’t pay unless we win your case.

Note: This information is based on incident reports provided by the U.S. Consumer Product Safety Commission. If you find information that is incorrect, please contact us immediately so we can correct the post to reflect accurate information.

Disclaimer: The information provided in this post is not intended to be legal or medical advice. This article is based on publicly available incident reports. The incidents mentioned have not necessarily been independently verified or adjudicated.

Schedule Your Free Consultation Now

Scroll to Top